EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

{ZnII2} and {ZnIIAuI} Metal Complexes with Schiff Base Ligands as Potential Antitumor Agents Against Human Glioblastoma Multiforme Cells

Lora Dyakova iD, Tanya Zhivkova iD, Abedulkadir Abudalleh iD, Daniela C Culita iD, Teodora Mocanu iD, Augustin M Madalan, Anamaria Hanganu iD, Gabriela Marinescu iD, Emanuil Naydenov, Radostina Alexandrova iD

Molecules · 2026

DOI: 10.3390/molecules31010173 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2026. Verfasst von Lora Dyakova und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Neurobiology, Bulgarian Academy of Sciences, Acad. Georgi Bonchev Str., Bl. 23, 1113 Sofia, Bulgaria. Hauptthemen laut MEDLINE: Antineoplastic Agents, Glioblastoma, Coordination Complexes, Zinc. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bulgarian Science Fund, National Science Fund, Bulgarian Ministry of Education and Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The challenges of glioblastoma multiforme treatment are related to limitations in tumor removal surgery, its high heterogeneity and aggressiveness, development of resistance to standard therapy, the blood–brain barrier, and the side and toxic effects of the conventional antitumor agents used in clinical practice. Although new treatment strategies continue to emerge, progress remains slow and has not resulted in substantial improvements in patient survival. The main goal of research in recent years has been aimed at developing ways to deal with all these challenges. One of the ways to improve the control of glioblastomas is the introduction of effective new antitumor agents. Metal complexes represent a particularly promising class of compounds in this context. This is why the aim of this study was to assess the effects of six homo- and heterometallic coordination compounds bearing Schiff base ligands—[Zn2(Ampy)(µ-OH)(H2O)2](ClO4)2 (ZnAmpy), [Zn2(Dmen)(µ-OH)(H2O)2](ClO4)2 (ZnDmen), 1∞[{Zn2(Ampy)(μ3-OH)}2(H2O){μ-[Au(CN)2]}](ClO4)3·THF·H2O (ZnAmpyAu), [{Zn2(Dmen)(μ-OH)}2{μ-[Au(CN)2]}{[Au(CN)2]2}](ClO4)·H2O (ZnDmenAu), 1∞[Zn(Salampy){μ-Au(CN)2}] (ZnSalampyAu), and 1∞[Zn(Saldmen)(μ-Au(CN)2}] (ZnSaldmenAu)—on the viability and proliferation of 8MGBA and U251MG human glioblastoma multiforme cells (HDmen and HAmpy are bicompartmental Schiff base ligands resulting from the condensation of 2,6-diformyl-p-cresol with N,N-dimethylethylenediamine and 2-(aminomethyl)pyridine, respectively, while HSaldmen and HSalampy are tridentate Schiff base ligands obtained via condensation of salicylaldehyde with N,N-dimethylethylenediamine and 2-(aminomethyl)pyridine, respectively). Among these compounds, ZnSaldmenAu is a new compound and is reported here for the first time. Cytotoxicity of the compounds was evaluated through analysis of cell viability, 2D/3D growth, cytopathological alterations, and induction of cell death. The results obtained by methods with different targets in cells and the associated mechanisms of action revealed that the compounds investigated show promising cytotoxic/potential antitumor activity in treated cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsGlioblastomaCoordination ComplexesZincHumansSchiff BasesLigandsCell Line, TumorCell ProliferationCell Survival

Stichwörter der Autor:innen

Zn(II) homometallic complexesZn(II)Au(I) heterometallic complexescytotoxic/antiproliferative activityglioblastoma multiforme

Substanzen

Schiff BasesAntineoplastic AgentsCoordination ComplexesLigandsZinc

Autor:innen und Institutionen

  • Institute of Neurobiology, Bulgarian Academy of Sciences, Acad. Georgi Bonchev Str., Bl. 23, 1113 Sofia, Bulgaria.
  • Institute of Experimental Morphology, Pathology and Anthropology with Museum, Bulgarian Academy of Sciences, Acad. Georgi Bonchev Str., Bl. 25, 1113 Sofia, Bulgaria.
  • Ilie Murgulescu Institute of Physical Chemistry, Romanian Academy, 202 Splaiul Independentei, 060021 Bucharest, Romania.
  • Department of Inorganic Chemistry, Organic Chemistry, Biochemistry and Catalysis, Faculty of Chemistry, University of Bucharest, 90-92 Panduri St., 050663 Bucharest, Romania.
  • "C.D. Nenitzescu" Institute of Organic and Supramolecular Chemistry of the Romanian Academy, 202B Splaiul Independentei, 060023 Bucharest, Romania.
  • Department of Neurosurgery, University Hospital St. Ivan Rilski, Blvd. "Acad. Ivan Geshov" 15, 1113 Sofia, Bulgaria.

ORCID-Profile: Lora Dyakova, Tanya Zhivkova, Abedulkadir Abudalleh, Daniela C Culita, Teodora Mocanu, Anamaria Hanganu, Gabriela Marinescu, Radostina Alexandrova

Förderung

  • Bulgarian Science Fund
  • National Science Fund, Bulgarian Ministry of Education and Science

Zitieren

APA

Dyakova, L., Zhivkova, T., Abudalleh, A., Culita, D. C., Mocanu, T., Madalan, A. M., Hanganu, A., Marinescu, G., Naydenov, E., & Alexandrova, R. (2026). {ZnII2} and {ZnIIAuI} Metal Complexes with Schiff Base Ligands as Potential Antitumor Agents Against Human Glioblastoma Multiforme Cells. Molecules. https://doi.org/10.3390/molecules31010173

Vancouver

Dyakova L, Zhivkova T, Abudalleh A, Culita DC, Mocanu T, Madalan AM, et al. {ZnII2} and {ZnIIAuI} Metal Complexes with Schiff Base Ligands as Potential Antitumor Agents Against Human Glioblastoma Multiforme Cells. Molecules. 2026. doi:10.3390/molecules31010173

BibTeX
@article{Dyakova2026,
  author = {Dyakova, Lora and Zhivkova, Tanya and Abudalleh, Abedulkadir and Culita, Daniela C and Mocanu, Teodora and Madalan, Augustin M and Hanganu, Anamaria and Marinescu, Gabriela and Naydenov, Emanuil and Alexandrova, Radostina},
  title = {ZnII2 and ZnIIAuI Metal Complexes with Schiff Base Ligands as Potential Antitumor Agents Against Human Glioblastoma Multiforme Cells},
  journal = {Molecules},
  year = {2026},
  doi = {10.3390/molecules31010173}
}
Kostenlos starten →